Screening Advances
Finding cancer early may make it easier to treat—and possibly cure. Imaging plays a role in screening to detect breast cancer (mammography) and lung cancer (CT). Vanderbilt has made recent advances in both areas, with the implementation of powerful new breast imaging technology and the launch of a lung cancer screening program.
Vanderbilt University honors 2 Radiology faculty as emeriti
Twenty retiring faculty members were recognized during Vanderbilt’s Commencement ceremony May 9, when the university honored their years of service and bestowed on them the title of emeritus or emerita faculty.
Two of them included Radiology faculty, Thomas S. Dina and Richard M. Heller, Professors of Radiology and Radiological Sciences.
PET Probe Detects Dying Tumor Cells
Noninvasive biomarkers that detect programmed cell death – apoptosis – would be valuable for predicting early responses to anticancer therapies and for improving drug discovery. Potential targets for molecular imaging of apoptosis include caspase enzymes, which play essential roles in apoptotic signaling pathways. H.
VICC Debuts Novel Neuroendocrine Tumor Treatment
Eric Liu, M.D., assistant professor of Surgery and Radiology and Radiological Sciences, is the principal investigator at Vanderbilt for the trial, dubbed NETTER-1.
“Neuroendocrine tumors are a difficult type of cancer to take care of because they have unusual traits,” Liu said. “Not only do these tumors grow but they also secrete hormones, which can create lots of symptoms. They can be quite difficult to diagnose and require a multi-modal approach to care.”
